Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes.

MLA

Di Savino, Augusta, et al. “Clinical Significance of TFR2 and EPOR Expression in Bone Marrow Cells in Myelodysplastic Syndromes.” British Journal of Haematology, vol. 176, no. 3, Feb. 2017, pp. 491–95. EBSCOhost, https://doi.org/10.1111/bjh.13968.

APA

Di Savino, A., Gaidano, V., Palmieri, A., Crasto, F., Volpengo, A., Lorenzatti, R., Scaravaglio, P., Manello, A., Nicoli, P., Gottardi, E., Saglio, G., Cilloni, D., & De Gobbi, M. (2017). Clinical significance of TFR2 and EPOR expression in bone marrow cells in myelodysplastic syndromes. British Journal of Haematology, 176(3), 491–495. https://doi.org/10.1111/bjh.13968

Chicago

Di Savino, Augusta, Valentina Gaidano, Antonietta Palmieri, Francesca Crasto, Alessandro Volpengo, Roberta Lorenzatti, Patrizia Scaravaglio, et al. 2017. “Clinical Significance of TFR2 and EPOR Expression in Bone Marrow Cells in Myelodysplastic Syndromes.” British Journal of Haematology 176 (3): 491–95. doi:10.1111/bjh.13968.